homeobox transcription factor 1B expression affects renal interstitial fibrosis and apoptosis in unilateral ureteral obstructed rats.
rior segment of the eye, and dopaminergic and serotonergic neurons (7, 8, 25) , and is commonly expressed in vertebrate embryos during early embryonic development.
Mutations of the Lmx1b gene are associated with malformation and dysfunction in numerous tissues. Most prominently, a large number of mutations in the Lmx1b gene have been described for nail-patella syndrome (NPS; MIM 161200) (3, 7, 25, 30, 31, 34) , also called hereditary osteoonychodysplasia. This is a rare autosomal dominant disease that is characterized by developmental defects in the dorsal limb structures, e.g., absent or small patellae, pelvis iliac horn malformation, and absent or hypoplastic nails (7) . In addition to these deformities, at least one-third of patients suffering from NPS present with nephropathy (3, 34) , and, clinically, Lmx1b expression correlates with an increased risk of developing nephropathy (3) . Lmx1b mutant mouse kidneys show irregular glomerular basement membrane thickening with sporadic membrane discontinuity and abnormal podocytes with a lack of foot process formation and slit diaphragms (5) . Furthermore, Lmx1b knockout mice show a significantly lower increase in glomerular volume and an increase in glomerulosclerosis (11) . Impairment of structural glomerular basement membrane integrity leads to proteinuria and hematuria, which are key inducers of renal interstitial fibrosis (RIF).
RIF commonly occurs in all forms of chronic kidney disease (4) , regardless of the etiology of the primary renal syndrome (40) , and is characterized by an enhanced and progressive accumulation of the extracellular matrix (ECM) and oxidative stress via hypoxia or other metabolic derangements in fibrotic tissue (17, 28) . The pathophysiological processes in RIF not only lead to oxidative stress but also cell necrosis and apoptosis, which are the final critical and detrimental outcomes for tissue stability and function; in apoptosis, caspases play a key role, which is well established for chronic kidney injury and renal fibrosis (32) . Because of LMX1B's role in various forms of nephropathy, we assumed that LMX1B might play a role in the development or progression of RIF. In fact, we recently found that LMX1B acts as a negative regulator of collagen type III, fibronectin (FN), the profibrotic factor transforming growth factor (TGF)-␤ 1 , and cleaved caspase-3 in hypoxic rat renal tubular epithelial cells (RTECs) (unpublished observations). Consequently, overexpression of LMX1B led to an attenuation of apoptosis, and, therefore, LMX1B might be a protective factor that suppresses renal fibrotic processes, i.e., ECM accumulation and deposition, and oxidative stress or its consequences. Furthermore, it is currently unknown if LMX1B may be considered a risk factor in various nephropathies other than NPS.
The present report is a continuation of the investigations in the cell system, and here we explore if our previous results can be confirmed in a (patho)physiologically more relevant setting, i.e., an animal model of RIF [unilaterally ureteral obstructed (UUO) rats]. The present evaluation might serve as a basis for further investigations regarding the effect of LMX1B expression on pathways involved in the various phenomena associated with RIF and for the development of novel therapeutic interventions.
MATERIALS AND METHODS

Animal Model of RIF
Animal model of UUO. Healthy male Wistar rats were obtained from the Experimental Animal Center of Guangxi Medical University (Nanning, China). Rats were maintained at ϳ22°C under a 12:12-h dark-light cycle and given food and water ad libitum. All experimental procedures involving laboratory animals were reviewed and approved by the Animal Ethics Committee of Guangxi Medical University and Sun Yat-Sen University.
For the assessment of renal morphological changes during UUO, rats (150ϳ180 g) were randomly divided into two groups: 1) a sham operation (SHO) group (n ϭ 40), which underwent exactly the same surgical procedures as the experimental group without the treatment under study, and 2) a model group subjected to UUO (n ϭ 40). The ureter was ligated at ϳ1 cm below the renal hilum with 3-0 silk suture. The abdominal wound was closed, and rats were returned to their cages. Control rats underwent an abdominal incision and approximation with no ligation of the ureter (45, 47) . Subsequently, 10 rats from both groups were euthanized 1, 2, 3, and 4 wk after surgery, and their renal tissue was collected for histological and molecular biological assessment.
Animal experiments and gene interference. Fifty healthy male Wistar rats (80ϳ100 g) were randomly divided into five groups: 1) a SHO group, 2) model group subjected to UUO, 3) UUO rats treated with lentivirus carrying Lmx1b small interfering (si)RNA (LMX1B Ϫ ), 4) UUO rats treated with lentivirus carrying LMX1B (LMX1B ϩ ), and 5) UUO rats treated with control viruses (n ϭ 10 rats/group). Lentivirus vectors and control viruses were purchased from Life TechnologiesInvitrogen (Grand Island, NY). Rats in the LMX1B Ϫ , LMX1B ϩ , and negative control virus groups were injected intraperitoneally from the second day after surgery for 3 consecutive days. Subsequently, 10 rats from those 5 groups were euthanized 96 h after the first injection, and their renal tissue was collected for further experimental assessment.
General Analysis Methods
Microscopic assessment of renal morphology. Renal morphological assessment was essentially performed as previously described (50) . Briefly, renal tissue was fixed (10% neutral formaldehyde), dehydrated via a graded ethanol series, and embedded in paraffin, and microtome-prepared sections were subsequently stained with Masson's trichrome stain. Renal morphology and pathology were evaluated by optical microscopy. Blue granular or linear deposits were interpreted as positive areas for collagen staining, and the severity of the renal lesions was expressed as the RIF index. Semiquantitative evaluation was performed by computer-assisted image analysis on a Leica DMRϩQ550 system (Leica Microsystems, Wetzlar, Germany) at ϫ400 magnification. The area of positive staining for fibrosis was measured in 20 fields (fields containing glomerular parts were ignored), which were randomly selected from coded sections for each rat (51) . RIF was scored from 0 to 3 as follows: 0 ϭ absent (n 0), 1 ϭ Ͻ25% of the area (n1), 2 ϭ 26 -50% of the area (n2), and 3 ϭ Ͼ50% of the area (n3) (33) . Sections were blind evaluated by two investigators, and the obtained scores were averaged. The RIF index was calculated according to the following equation:
Immunohistochemical analysis of renal protein expression. Fixed renal tissue (4% buffered paraformaldehyde) was embedded in paraffin, and 4-m-thick sections were subjected to immunohistochemical staining for LMX1B, TGF-␤1, collagen type III, FN, and cleaved caspase-3. To recover antigenicity, sections were deparaffinized by microwave treatment (10 mmol/l sodium citrate buffer, 10 min), washed with PBS, and treated with 3% H 2O2 in methanol for 10 min. Subsequently, all sections were incubated with anti-LMX1B (1:500), anti-TGF-␤1 (1:500), anti-collagen type IV (1:100), anti-FN (1:200) (all from Abcam, Cambridge, MA), or anti-cleaved caspase-3 (Thermo Fisher Scientific, Runcorn, UK) primary antibodies, respectively, and visualized after incubation with secondary antibody and staining with diaminobenizidine (Maixin Bio, Fuzhou, China). Positive areas were measured quantitatively using a computer-aided manipulator on a Leica DMRϩQ550 system (fields containing glomerular parts were ignored). All evaluations were performed blind by two investigators.
Real-time RT-PCR to detect LMX1B and TGF-␤ 1 mRNA expression. Renal tissue was homogenized, and total RNA was extracted with TRIzol (Life Technologies-Invitrogen). Signals were measured with a Gel Doc XRϩ, UV/vis-Molecular Imager (Bio-Rad Laboratories, Hercules, CA), and evaluation of the 18S and 28S RNA bands after agarose gel electrophoresis confirmed that there had been no RNA degradation (1) . Primers were designed according to the following standard primer design principles with Primer Premier 5.0 (Premier Biosoft, Palo Alto, CA): LMX1B, forward 5=-GCAGCCAGAATAAGGGCAGTG-3= and reverse 5=-TGGAGGAGACCTCAAACGAAGC-3=; TGF-␤ 1, forward 5=-CGC-AATCTATGACAAAACCAAA-3= and reverse 5=-TTCTACGTGTT-GCTCCACAGTT-3=; and ␤-actin, forward 5=-GCCCCTGAGGAGCAC-CCTGT-3= and reverse 5=-ACGCTCGGTCAGGATCTTCA-3=.
One microgram of total RNA from renal tissue was reverse transcribed into cDNA with an ExScript RT reagent kit (Thermo Scientific-Fermentas, Waltham, MA). LMX1B and TGF-␤ 1 were amplified with SYBR Premix Ex Taq (Roche, Basel, Switzerland). Gene expression of the housekeeping ␤-actin (Actb) was used as an internal loading control and to determine reverse transcription efficiency. The average threshold cycle (C t; the cycles of template amplification to the threshold) was determined for each sample, and the fold change in the data was analyzed using 2
Ϫ⌬⌬Ct method according to Ref. 23 . Western blot analysis. Proteins were isolated from homogenized renal tissue with RIPA lysis buffer (Sigma-Aldrich) containing 0.25 nM of the protease inhibitor PMSF (Sigma-Aldrich). After protein concentration, quantization was performed with the modified Bradford assay (Bio-Rad Laboratories) (38) , and 40 mg total protein was subsequently used for Western blot analysis with primary antibodies against LMX1B, TGF-␤ 1, collagen type III, FN, and cleaved caspase-3. ␤-Actin was used as an internal loading control. Nearinfrared fluorescence signals from manually selected bands of interest were imaged with an Odyssey Fc scanner (Li-Cor, Lincoln, NE). Raw fluorescence intensities were background subtracted (intralane) using Li-Cor Odyssey 3.0 analytic software (12) .
Evaluation of cell apoptosis in renal tissue. Apoptosis was examined via TUNEL (Roche), as previously described (13, 15) . In brief, 6 slides from each kidney were evaluated microscopically for the percentage of apoptotic cells: on each section, 20 watch fields (glomerular parts were excluded) were randomly chosen and evaluated. Brown staining of the cell nuclei was considered positive for apoptotic cells, and the apoptosis index was calculated according to the following equation (15):
The scores obtained by two investigators were averaged. ROS, lipid peroxidation, and antioxidant measurements in renal tissue. ROS measurements were essentially performed according to Hempel et al. (14) with some modifications. Excised renal tissue was washed, weighed, and subsequently homogenized in ice-cold 0.9% normal saline solution. The homogenate was centrifuged at 4,000 g for 15 min at 4°C, and the supernatant (500 l) was incubated for 3 h at 37°C with 10 l of a 10 M 2,7-dichlorodihydro-fluorescein diacetate solution (Life Technologies-Molecular Probes, Eugene, OR). The fluorescence signal was measured at 485/525 nm on a S-3100 spectrofluorometer (Scinco, Seoul, Korea) equipped with a 1,024-channel photodiode array detector and expressed as arbitrary units.
Malondialdehyde (MDA), glutathione (GSH), and SOD were determined as extensively described by Wu et al. (44) . Kidney tissue was homogenized in 0.1 M phosphate buffer (pH 7.4) using a Ultra Turrax-T18-basic homogenizer (IKA Works, Wilmington, NC), and the homogenate was centrifuged at a 10,000 g at 4°C for 15 min to remove cellular debris. The supernatant was used for the estimation of MDA and GSH levels as well as SOD activity. The protein concentration in samples was determined with a bicinchoninic acid protein assay kit (Sigma-Aldrich) with BSA as the standard. Absorbance was measure spectrophotometrically at 562 nm.
Statistical Analysis
All data are shown as means Ϯ SD. To compare groups in relation to parameters with normal distribution, one-way ANOVA with a post hoc Fisher's least-significant-difference test was used. Conversely, for those parameters without normal distribution, a Kruskal-Wallis test with a post hoc Mann-Whitney test (only for the weight parameter) was used. Pearson's correlation coefficients (r) were used to determine the relationships between parameters for detection in the animal experiments. P values of Ͻ0.05 were accepted as statistically significant. Statistical analysis was performed using SPSS (version 13.0, SPSS, Chicago, IL).
RESULTS
LMX1B in a UUO Rat Model of Renal Fibrosis
Renal fibrosis assessment in UUO rats. Various impairments of the urinary and renal tract are major causes of progressive renal disease in humans. Since UUO is a well-characterized model for experimental nephropathy (26), we opted to further investigate the role of LMX1B in this in vivo model system. Lentivirus-based vectors were used to deliver either siRNA to knock down LMX1B protein expression or the Lmx1b gene to attain exactly the opposite effect. We recently found in RETCs subjected to hypoxia/reoxygenation that increased levels of LMX1B reduced factors promoting ECM accumulation and RIF, including TGF-␤ l , collagen type III, and FN, and attenuated cleaved caspase-3 expression and, consequently, cell apoptosis (unpublished observations).
LMX1B staining (%)
Our observations in the UUO rat model showed that hypoxic conditions in this model per se increased overall collagen deposition ϳ20-fold after 14 days and doubled once more after another 14 days of obstruction (Fig. 1A ) compared with the SHO group (the control group that underwent the same surgical procedure as the UUO group without the treatment under study). As shown in Fig. 1B , a clear loss of tissue integrity was observed in the UUO group, with collapsed lumina, tubular dilation, and increased diffuse fibroblast infiltration in the renal interstitium (from multiple slide evaluation). The results from the Masson staining showed that collagen deposition increased at least 24.5-fold after 14 days and ϳ41-fold after 28 days (day 14 ¡ day 28 ϭ 1.7) compared with the SHO group. Since collagen deposition is a major hallmark of RIF, these results confirm that the UUO model was an appropriate choice for further investigations on the role of LMX1B in renal nephropathy under controllable conditions.
Expression of LMX1B and ECM components. Recently, we found that LMX1B was expressed in a RTEC model system and reduced under hypoxia/reoxygenation (unpublished observations). However, Suleiman and co-workers (37) reported that in vivo, LMX1B is exclusively expressed in the glomerulus but not in tubular cells, which effectively contradicted our results in the RTEC model system. Here, we used a physiologically relevant rat model of RIF (induced via UUO) that showed all morphological changes associated with RIF induction in nephropathies, as shown in Fig. 1 . Immunohistochemical staining for LMX1B in our rat model (Fig. 2) clearly showed that LMX1B was distinctly expressed in both the glomerulus and tubule lining and thus also in RTECs.
Evaluation of renal sections with respect to LMX1B levels showed progressively decreasing expression by a factor of ϳ2.3 at 14 days and ϳ4.1 after 28 days compared with the control SHO group (Fig. 3A) . Concomitantly, major proteins involved in ECM derangements, i.e., collagen type III and FN, and the profibrotic factor TGF-␤ 1 increased with time by a maximum factor of ϳ15.8 (collagen type III), ϳ22 (FN), and ϳ9 (TGF-␤ 1 ) after 28 days (Fig. 3, B-D) . Doubling of the UUO time from 14 to 28 days resulted in a further decrease in LMX1B expression by a factor of ϳ2, whereas a possible saturation in collagen type III (14 ¡ 28 days: ϳ1.51), FN (ϳ1.57), and TGF-␤1 (ϳ1.42) occurred. Cleaved caspase-3 (Fig. 3E) , as a major marker for apoptosis, increased progressively with time by a factor of ϳ7 (14 days) and ϳ9.5 (28 days) compared with control, indicating that apoptosis is a key mode of cell death during UUO conditions in the kidney. Finally, compared with control, the micrographs also revealed an increasingly compromised renal morphology and loss of tubule integrity.
Further assessment of the mRNA and protein expression of LMX1B and profibrotic components under hypoxic conditions in the kidney of UUO rats was performed, as shown in Figs. 4 and 5. TGF-␤ 1 was particularly scrutinized, because TGF-␤ 1 is regarded as a key mediator of interstitial fibrosis, which both affects pro-and antifibrotic signaling. The results shown in Fig.  4 demonstrate that mRNA expression of LMX1B in renal tissue of the UUO group was progressively reduced (day 14/day 28: factor ϳ2.9/ϳ10, day 14 ¡ day 28 ϭ 3.4) and TGF-␤ l increased (day 14/day 28: factor ϳ5.3/ϳ9.7, day 14 ¡ day 28 ϭ 1.7) with time compared with the control SHO group (all P Ͻ 0.01). From the change in TGF-␤ 1 mRNA levels, it may be concluded that reduction of LMX1B promotes the profibrotic capacity in UUO tissue.
Assessment of the protein levels of LMX1B and proteins involved in RIF by Western blot analysis (Fig. 5 ) revealed that these were in better agreement with the immunohistochemistry results (Fig. 3) than the mRNA measurements. Furthermore, expression of the various proteins in the control SHO group remained exactly the same over the 4-wk period (Fig. 5A) , indicating stabile renal function even after the sham operation. LMX1B protein levels in renal tissue of the UUO group were progressively reduced (day 14/day 28: factor ϳ2.3/ϳ3.1, day 14 ¡ day 28 ϭ 1.3) over the 28-day period versus the RNA measurements (day 14/day 28: factor ϳ2.9/ϳ10, day 14 ¡ day 28 ϭ 3.4), although an equal trend was observed. Conversely, TGF-␤ 1 protein levels were in good agreement with the mRNA measurements (day 14/day 28: factor ϳ5.1/ϳ8.9, day 14 ¡ day 28 ϭ 1.6). Although the measurements have a semiquantitative nature, this alone does not explain the observed discrepancy, and we therefore speculate that some interference occurred between LMX1B transcription and translation, which requires further investigation. The extent of the expression of collagen type III and FN was elevated on average by a factor of 2.5 and increased from day 14 ¡ day 28 by a factor of ϳ1.5 and ϳ1.3, respectively. Effect of LMX1B on oxidative stress and cell apoptosis. To determine the extent of the induced oxidative stress in hypoxic UUO renal tissue, indicators of oxidative stress and antioxidant status were determined. Furthermore, since apoptosis is an important detrimental outcome of RIF, apoptotic cell death under UUO conditions was evaluated. As shown in Fig. 6A , ROS generation and lipid peroxidation, as assessed by MDA measurements, was significantly higher in the UUO group compared with the control SHO group. The endogenous antioxidants (Fig. 6B) , i.e., SOD and GSH, were concomitantly compromised. Overall, ROS and MDA were generally increased by a factor of ϳ3 and SOD and GSH decreased by a factor of ϳ2 after 2 wk: the effects nearly doubled when the UUO time doubled (day 14 ¡ day 28: ROS ϭ 1.8, MDA ϭ 1.4, SOD ϭ 2.5, and GSH ϭ 2.3).
Since such high levels of endogenous ROS were observed and endogenous antioxidants were compromised, and because RIF is associated with caspase-3 activation, we evaluated the extent of apoptosis in UUO renal tissue. Assessment of the expression of cleaved caspase-3 (the activated form, which plays a central role in the execution phase of cell apoptosis), as shown in Fig. 5 , demonstrated that cleaved caspase-3 expression dramatically increased (day 14/day 28: factor ϳ5.3/ϳ7.7, day 14 ¡ day 28 ϭ 1.5) under UUO, which indicates activation of the intrinsic (mitochondrial) pathway of apoptosis. TUNEL staining for cell apoptosis (Fig. 7) showed significantly higher numbers of apoptotic cells in the renal interstitium of the UUO group compared with the SHO group (day 14/day 28: factor ϳ8.2/ϳ11.7, day 14 ¡ day 28 ϭ 1.4). Furthermore, a clear loss of tissue integrity was observed, including ruffled structures and tubular collapse. Interestingly, apoptotic staining in the tissue slides was also observed in RTECs, as deducible from the cell position in the samples (Fig.  7B ). This observation is consistent with the microscopic assessment that LMX1B is expressed in RTECs (Fig. 2) might be a further indication of the importance of LMX1B in counteracting proapoptotic processes. Correlation analysis. LMX1B protein levels were positively correlated with SOD and GSH (r ϭ 0.865 and 0.793, both P Ͻ 0.01). However, the LMX1B protein level was negatively correlated with the RIF index, TGF-␤ l , collagen type III, FN, cleaved caspase-3, the cell apoptosis index, ROS, and MDA (r ϭ Ϫ0.756, Ϫ0.698, Ϫ0.921, Ϫ0.923, Ϫ0.843, Ϫ0.794, Ϫ0.883, and Ϫ0.825, all P Ͻ 0.01).
Effect of LMX1B Expression Modulation Via Overexpression or Gene Interference in a UUO Rat Model of Renal Fibrosis
LMX1B expression modulation and ECM components.
Since the results presented above indicated that LMX1B expression might affect the extent of fibrotic lesions, the level of oxidative stress in the tissue, and ultimately the extent by which functional tissue is lost through apoptosis, we examined how LMX1B expression modulation affected tissue under UUO conditions. Lentivirus-based vectors were used to deliver either siRNA to knock down LMX1B protein expression or the Lmx1b gene to attain exactly the opposite effect. Rats were randomly divided into the following five groups:
, and 5) UUO rats treated with control viruses.
Assessment of mRNA and protein expression of LMX1B and profibrotic components in UUO rat kidneys under LMX1B modulation was performed as shown in Figs. 8 and 9 . LMX1B knockdown via siRNA resulted in a reduction in mRNA levels by a factor of ϳ6.7 compared with the SHO group and was virtually complete (15% remaining) and was reduced by a factor of ϳ3.7 compared with the already reduced levels (UUO group ¡ SHO group: ϳ1.8) in the UUO group (Fig. 10) . Conversely, LMX1B overexpression increased mRNA levels by a factor of ϳ5.7 over SHO levels and ϳ10.4 compared with UUO levels. As a result of LMX1B knockdown, TGF-␤ 1 mRNA levels doubled compared with the UUO group, whereas LMX1B overexpression reduced TGF-␤ 1 mRNA levels significantly by a factor of ϳ1.5 compared with the UUO group. However, LMX1B overexpression was unable to reduce TGF-␤ 1 mRNA levels to control SHO levels (still ϳ1.6 higher) and, therefore, some profibrotic capacity remained.
Further assessment of this profibrotic capacity and the effect of LMX1B modulation on ECM components by Western blot analysis showed that LMX1B knockdown resulted in a reduction in protein levels by a factor of ϳ4.4 compared with the SHO group (22.7% remaining) and was reduced by a factor of ϳ1.9 compared with the UUO group (Fig. 11A) . Clearly, knockdown of LMX1B increased ECM components ϳ1.5-to 1.9-fold versus the UUO group. Overexpression increased LMX1B protein levels ϳ2.5 times compared with the control SHO group and at least ϳ5.7 times compared with the UUO group. This increase had a considerable effect on the extent of the expression of ECM components, since these decreased on average ϳ1.5-fold compared with the UUO group (TGF-␤ 1 : ϳ1.7, collagen type III: ϳ1.5, and FN: ϳ1.4). Nonetheless, in agreement with the mRNA measurements, a considerable profibrotic capacity remained, since ECM component levels were still ϳ2-fold higher than the control SHO group.
Effect of LMX1B modulation on oxidative stress and cell apoptosis. Because in UUO oxidative stress was significantly induced, and LMX1B overexpression was able to reduce the effects of RIF, we investigated if and to what extent LMX1B modulation was able to affect oxidative stress (Fig. 10) and apoptosis (Fig. 11 ). ROS and MDA levels (Fig. 10A ) in LMX1B knockdown kidneys were increased by a factor of ϳ3.5 and ϳ5, and SOD and GSH levels (Fig. 10B) were concomitantly reduced by a factor of ϳ2 and ϳ1.6 compared with the SHO group. Compared with the UUO group, ROS and MDA levels increased by a factor of ϳ1.8 and ϳ1.4, and SOD and GSH levels decreased by a factor of ϳ1.6 and ϳ2.8. Interestingly, LMX1B depletion had a significant effect on lipid peroxidation relative to total ROS levels, which shows that biomembranes are prime targets during fibrotic processes. LMX1B overexpression was able to reduce ROS and MDA levels by an average factor of ϳ1.4 and increase SOD and GSH by ϳ1.3. However, overexpression was unable to reduce oxidative stress to control SHO levels (still ϳ3.1 times higher for ROS/MDA and ϳ1.4 lower for SOD/GSH), which was in agreement with the protein level measurements.
Apoptosis is a final detrimental outcome of oxidative stress and has been observed in a number of nephropathies, including those in which RIF is a key manifestation. Evaluation of cleaved caspase-3 levels in response to LMX1B modulation (Fig. 9A) showed that levels doubled (ϳ1.9) under LMX1B knockdown compared with the UUO group (ϳ8.8-fold higher than the SHO group). However, overexpression of LMX1B only moderately reduced its expression by a factor of ϳ1.7, leaving the levels still increased 2.7-fold compared with the control SHO group. Thus, a significant proapoptotic potential remained. The results of subsequent TUNEL assessment verified this, and the results shown in Fig. 11 demonstrate that the cell apoptosis index increased ϳ1.4 times upon LMX1B knockdown and decreased ϳ1.7 times as a result of LMX1B overexpression compared with the UUO group. This, however, was still ϳ4.8 times higher than the control SHO group, and, thus, LMX1B overexpression was unable to ameliorate apoptosis altogether.
Correlation analysis. LMX1B protein levels were positively correlated with SOD and GSH (r ϭ 0.788 and 0.836, both P Ͻ 0.01). However, the LMX1B protein level was negatively correlated with the RIF index, TGF-␤ l , collagen type III, FN, cleaved caspase-3, the cell apoptosis index, ROS, and MDA (r ϭ Ϫ0.832, Ϫ0.794, Ϫ0.843, Ϫ0.903, Ϫ0.816, Ϫ0.874, Ϫ0.842, and Ϫ0.784, all P Ͻ 0.01).
DISCUSSION
Numerous chronic renal diseases share common morphological changes, especially interstitial ECM accumulation, which contributes significantly to the loss in renal function. Among the numerous cell types involved, e.g., fibroblasts, fibrocytes, myofibroblasts, monocyte/macrophages, and mast cells, RTECs are purported to play a considerable role and contribute to increased ECM deposition (39, 43) . RTECs undergo distinct phenotypic changes in dysfunctional tissue and have been shown to promote interstitial fibrosis via numerous signals and molecular mediators, including TGF-␤ 1 . TGF-␤ 1 , the latent form of TGF-␤ that is bound to latency-associated peptide, is one of the key factors known to play a pathogenic role in renal fibrosis and is regarded to be a central mediator that induces the deposition of ECM components, especially collagen type III and FN (17, 22) . In renal disease, TGF-␤ is commonly upregulated and exerts its profibrotic signaling through the Smad (20, 27) and jagged/notch (21, 36) pathways and Crim1, which, in turn, regulates TGF-␤ 2 , VEGF, and PDGF-␤ (42). For these reasons, TGF-␤ was particularly scrutinized in our investigations. ECM components, such as collagen type III and FN, are important indicators of fibrosis and are clinically used to evaluate the severity of RIF lesions. The Lmx1b gene plays a pivotal role in glomerular development (31, 34) , and various mutations in the Lmx1b gene have been reported in patients suffering from NPS, in which onethird of patients show renal fibrotic changes (30, 31, 41) . Furthermore, studies in LMX1B mutant and knockout mice have shown irregular thickening of the glomerular basement membrane, abnormal podocytes, a significantly lower increase in glomerular volume, and an increase in glomerulosclerosis (5, 11) . Since the exact role that LMX1B plays in various nephropathies is largely unknown, we investigated if LMX1B might play a role in the progression of RIF. In a RTEC model system, we recently found that LMX1B acts as a negative regulator of TGF-␤ 1 , collagen type III, FN, oxidative stress, and cleaved caspase-3 and apoptosis under hypoxia/reoxygenation conditions (unpublished observations). Our results are contradicted by a study performed by Suleiman et al., who showed that, in vivo, LMX1B is exclusively expressed in the glomerulus and not in other portions of the nephron, including tubular cells. Their results were based on work performed in Cre-lox podocyte-specific knockout mice, and it was assumed that, compared with conventional knockout approaches, no compensatory mechanisms would develop. Nonetheless, the use of this system might still result in unknown and unexpected side effects, and, for this reason, we opted to use a knockdown approach that circumvents direct interference with the gene's expression, i.e., by RNA interference. Furthermore, we are aware of the increasing discussion on the significance of the epithelial-to-mesenchymal transition (EMT) (2), which purports that during tubular injury, epithelial cells lose their phenotype, repress epithelial markers (e.g., E-cadherin and cytokeratins), acquire mesenchymal properties, and express myofibroblast markers (e.g., vimentin, calmodulin, and ␣-smooth muscle actin) (39, 43) . Concomitantly, epithelial cells lose polarity, acquire increased motility, and are able to traverse basement membranes into the interstitium. Recent emerging experimental results have contradicted the EMT hypothesis, and, consequently, the paradigm has shifted away from epithelial cells to other cell types, predominantly fibroblasts, and the impact of RTEC dysfunction on RIF is now being questioned. However, in our UUO system, which closely mimics the conditions in obstructive nephropathies, including hypoxia, we distinctly observed staining for LMX1B in the glomerulus and tubule lining and, therefore, RTECs (Fig. 2) . Furthermore, the final detrimental outcome of RIF, apoptosis, was particularly observed in a large number of RTECs under UUO conditions (Fig. 7B) . In general, these results validate the biological relevance of RTEC model system experiments. Additionally, the importance of RTECs in fibrotic processes, apart from EMT and epithelial cell migration, was recently underscored by Moll and coworkers (29) . These authors showed that RTECs play a significant role in fibrosis and can control and regulate fibroblast phenotype, which both emphasizes the importance of cellular cross-talk in RIF and the fact that RTECs are relevant target cells for the development of novel antifibrotic therapeutic approaches. The hypoxic conditions and concomitant disruption of cellular homeostasis during UUO resulted in a progressive increase in TGF-␤ 1 , collagen type IV, and FN, all factors that contribute to ECM deposition and RIF, over the 28-day evaluation. Morphologically, distinct changes were observed, including tubular dilation, a ruffled appearance of renal structures, increased areas of fibrosis, and diffuse fibroblast-like cells in tubulointerstitial tissue of the obstructed kidney (Figs.  1B and 3) , as commonly observed in UUO rats/mice. Concomitantly, LMX1B protein expression was reduced at least 3-fold (day 14/day 28: factor ϳ2.3/ϳ3.1, day 14 ¡ day 28 ϭ 1.3) over the 28 days of UUO (32% remaining), accompanied by increased oxidative stress (ϳ5-fold), compromised key antioxidants (ϳ4.5-fold), and increased cleaved caspase-3 expression and apoptosis. Tubules with TUNEL-positive epithelia were significantly increased, which is in concordance with studies by Kim et al. (19) and Yeh et al. (46) , who showed that positive cells for cleaved caspase-3 were significantly increased in RTECs and tubulointerstitial cells. Furthermore, Kida et al. and Sato et al. determined that a positive linear relationship exists between tubular dilatation and tubular epithelial apoptosis in UUO mice (18) . Increased ROS, lipid peroxidation, and compromised antioxidants were previously found in a number of studies using obstructed rodent kidneys (6, 24, 35, 48) , and ROS have been suggested to impair the integrity of the glomerular basement membrane, reduce podocyte proteoglycan de novo synthesis, and stimulate factors promoting ECM deposition, including TGF-␤ 1 (9) , as similarly observed in the present study. Overall, these results corroborate our results in the RTEC model system.
Modulation of LMX1B expression via lentivirus transduction with Lmx1b or LMX1B siRNA showed that knockdown of LMX1B expression beyond the already reduced expression due to UUO (ϳ1.9-fold) significantly aggravated the deposition of ECM components (ϳ1.5-to 1.9-fold) and expression of TGF-␤ 1 , oxidative stress, and apoptosis (Fig. 12) . Conversely, overexpression increased LMX1B protein levels at least ϳ5.7-fold compared with the UUO group, which resulted in a significant reduction of ECM components and TGF-␤ 1 (TGF-␤ 1 : ϳ1.7, collagen type III: ϳ1.5, and FN: ϳ1.4). Nonetheless, a considerable profibrotic capacity remained, since ECM component levels were still ϳ2-fold higher than the control SHO group, which was accompanied with elevated oxidative stress levels and apoptosis. We observed similar phenomena when modulating prohibitin levels, although here the reduction was significantly higher, particularly with respect to the reduction of oxidative stress and apoptosis (unpublished results).
Alternate mechanisms might still promote the expression of TGF-␤ 1 , which seems to play a central role. Further assessment of the interaction partners of LMX1B might shed more light on the exact role that LMX1B plays in TGF-␤ 1 expression and RIF. Alternatively, the desired reduction in TGF-␤ 1 , ECM components, and oxidative stress might only be achievable by combining overexpression strategies with multiple targets. Furthermore, the results presented here should be confirmed in patients suffering from nephropathies (other than NPS). We are currently investigating the involvement of LMX1B in pediatric patients suffering from primary nephrotic syndrome. Nonetheless, the results obtained in UUO rats closely follow the results in the hypoxia/reoxygenation RTEC model system, albeit that particularly the observed reduction of profibrotic components, oxidative stress, and apoptosis was more pronounced, which leads us to believe that LMX1B plays a more prominent role in RTECs and that LMX1B depletion in RTECs might possibly affect other cell types in the nephron. Further analysis in a three-dimensional mixed renal cell culture in which RTECs are specifically targeted for LMX1B modulation are currently planned and might provide some insights if and to what extent LMX1B modulation in RTECs affects other cell types.
In conclusion, reduced LMX1B levels clearly represent a risk factor for RIF, whereas overexpression affords some level of protection against RIF or at least attenuates the onset and progression of fibrosis. In general, LMX1B may be considered to be a negative regulator of the RIF index, TGF-␤ 1 , collagen type III, FN, cleaved caspase-3, oxidative stress, and cell apoptosis.
